Manufacturer Recalls Glucagon Emergency Kit Due to Potential Loss of Potency
By Adam Hochron, Staff Writer
December 22, 2021
The manufacturer of the Glucagon Emergency Kit for Low Blood Sugar has announced a voluntary recall of one batch due to a potential loss of potency.
According to a release from the manufacturer, the recall is for lot D239382D of the glucagon for injection 1 mg per vial; diluent for glucagon, 1mL syringe. The recall comes after a product complaint of the vial containing a liquid rather than powder. The release noted that an investigation found that the change in form could be related to manufacturing issues. Using the vial as a liquid could affect treating a patient’s low blood sugar levels.
The emergency kit is an anti-hypoglycemic agent used to treat severe hypoglycemia in pediatric and adult patients with diabetes mellitus.
The manufacturer is contacting distributors and customers to arrange the return and replacement of all the vials in the lot. They encourage wholesale and distribution companies to stop distributing the recalled product immediately. They also encouraged wholesalers and pharmacists to contact any customers who may have the affected batch.
Photo Credit: Getty Images
MORE FROMType 2 Diabetes Advanced Learning Center
![Metformin May Reduce Delirium Risk in Older Adults with Type 2 Diabetes](/CMSImagesThumbnails/2024/11/SO/sunrisesenior-md.jpg)
Metformin May Reduce Delirium Risk in Older Adults with Type 2 Diabetes
November 22, 2024![Dorzagliatin Raises Insulin Secretion, Glucose Sensitivity](/CMSImagesThumbnails/2023/01/ML/photo_audit/116406615_med.jpg)
Dorzagliatin Raises Insulin Secretion, Glucose Sensitivity
January 23, 2023![FDA Issues Class I Recall for Omnipod DASH Insulin](/CMSImagesThumbnails/2022/1/AJ/ALC/medical_board_meeting_med.jpg)
FDA Issues Class I Recall for Omnipod DASH Insulin
December 15, 2022![FDA Greenlights New Diabetes Drug](/CMSImagesThumbnails/2022/12/AS/alc-type2-d-threapy-med.jpg)
FDA Greenlights New Diabetes Drug
December 07, 2022![COVID-19 Increases Risk of Diabetes](/CMSImagesThumbnails/2022/05/AS/alc-diabetes-covid(med).jpg)
COVID-19 Increases Risk of Diabetes
May 06, 2022![ADA: Collaborative Care Key to Diabetes, Comorbidities Management](/CMSImagesThumbnails/2022/1/AJ/doctors_group_white_coat_med.jpg)
ADA: Collaborative Care Key to Diabetes, Comorbidities Management
January 12, 2022![New Type of Topical Cream Can Help Treat Diabetic Foot Ulcers](/CMSImagesThumbnails/2021/11/AJ/ALC/elderly_patient_med.jpg)